Intrapartum Ultrasound in Labor: Sonography Only, Few Internal Examinations
Launched by LARRY HINKSON · Feb 13, 2024
Trial Information
Current as of July 27, 2025
Recruiting
Keywords
ClinConnect Summary
This clinical trial is studying the use of ultrasound during labor to see if it can help reduce the risk of infections compared to the traditional method, which often involves more physical examinations. The researchers want to find out if using ultrasound makes mothers feel more satisfied with their experience and if it affects the overall outcomes of the birth.
To participate in this study, women must be at least 18 years old, pregnant with a single baby in the head-down position, and in labor that started on its own. However, there are some situations that would not allow a woman to join, like if there are serious health concerns for the mother or baby. If eligible, participants can expect to have fewer internal examinations during labor, as the study focuses on using ultrasound instead. Overall, this trial aims to explore a potentially safer and more comfortable approach to monitoring labor.
Gender
FEMALE
Eligibility criteria
- Inclusion Criteria:
- • Pregnant women of at least 18 years of age with a singleton in the cephalic position
- • Spontaneous onset of labor; births after induction of labor with otherwise suitable inclusion and exclusion criteria are also permitted.
- Exclusion Criteria:
- • Emergency situations such as maternal or fetal bleeding
- • Indication for urgent delivery by caesarean section
- • Pathological cardiotocogram
- • non-cephalic positions
- • under 18 years of age
- • women giving birth who are unable to give consent
About Larry Hinkson
Larry Hinkson is a dedicated clinical trial sponsor with extensive experience in overseeing and managing clinical research initiatives. Committed to advancing medical science, he ensures the highest standards of compliance, safety, and ethical considerations throughout the trial process. With a focus on innovative therapies, Larry collaborates with healthcare professionals and research institutions to facilitate the development of effective treatments, ultimately aiming to improve patient outcomes and contribute to the broader medical community. His leadership and expertise in clinical trial management position him as a trusted partner in the pursuit of groundbreaking healthcare solutions.
Contacts
Jennifer Cobb
Immunology at National Institute of Allergy and Infectious Diseases (NIAID)
Locations
Berlin, , Germany
Patients applied
Trial Officials
Larry Hinkson, FRCOG
Principal Investigator
Charité University Hospital Department of Obstetrics
Timeline
First submit
Trial launched
Trial updated
Estimated completion
Not reported